Back to Companies
TriSalus Life Sciences, Inc.
TLSINasdaqCIK: 0001826667
Recent Form 4 activity at TriSalus Life Sciences, Inc. (TLSI) spans 33 filings across 14 insiders (5 buying and 4 selling). Purchases total $1.8M against $134.4K in sales — heavily weighted toward buying, for a net purchase of $1.7M. Patience David (Chief Financial Officer) is the most active by dollar volume, and the single largest transaction was $1.5M by Stansky Michael P. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$10.7M
Purchases
$1.8M
Sales
$134.4K
Unique Insiders
14
Recent Insider Trades
33 loaded
| Jul 6 | TLSI TriSalus Life Sciences, Inc. | Patience David | Chief Financial Officer | Tax withheld | $65.3K |
| Jul 1 | TLSI TriSalus Life Sciences, Inc. | Szela Mary T | CEO and President, Director | Grant | $15.4K |
| Jul 1 | TLSI TriSalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Officer | Grant | $2.2K |
| Jun 29 | TLSI TriSalus Life Sciences, Inc. | Marshall Richard Henry | Chief Medical Officer | Grant | $568.8K |
| Jun 29 | TLSI TriSalus Life Sciences, Inc. | Marshall Richard Henry | Chief Medical Officer | Other | $0 |
| May 18 | TLSI TriSalus Life Sciences, Inc. | Stansky Michael P | Director | Buy | $1.5M |
| May 18 | TLSI TriSalus Life Sciences, Inc. | Patience David | Chief Financial Officer | Buy | $17.3K |
| May 18 | TLSI TriSalus Life Sciences, Inc. | Gordon Gary B. | Director | Buy | $24.6K |
| May 18 | TLSI TriSalus Life Sciences, Inc. | Wahlstrom Mats | Director | Buy | $151.8K |
| May 18 | TLSI TriSalus Life Sciences, Inc. | Szela Mary T | CEO and President, Director | Buy | $102.8K |
| May 15 | TLSI TriSalus Life Sciences, Inc. | MATLIN DAVID J | Director | Grant | $142.1K |
| May 15 | TLSI TriSalus Life Sciences, Inc. | Gordon Gary B. | Director | Grant | $142.1K |
| May 15 | TLSI TriSalus Life Sciences, Inc. | Valle William | Director | Grant | $142.1K |
| May 15 | TLSI TriSalus Life Sciences, Inc. | HICKS KERRY R | Director | Grant | $142.1K |
| May 15 | TLSI TriSalus Life Sciences, Inc. | Wahlstrom Mats | Director | Grant | $189.5K |
| May 15 | TLSI TriSalus Life Sciences, Inc. | Stansky Michael P | Director | Grant | $118.4K |
| Mar 20 | TLSI TriSalus Life Sciences, Inc. | Szela Mary T | CEO and President, Director | Sell | $79.4K |
| Mar 20 | TLSI TriSalus Life Sciences, Inc. | Stevens Jennifer | Chief Regulatory Officer | Sell | $14.5K |
| Mar 20 | TLSI TriSalus Life Sciences, Inc. | Devlin Jodi | Chief of Clinical Operations | Sell | $13.2K |
| Mar 20 | TLSI TriSalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Officer | Sell | $14.2K |
| Mar 20 | TLSI TriSalus Life Sciences, Inc. | Cox Bryan F. | Chief of Research | Sell | $13.1K |
| Feb 11 | TLSI TriSalus Life Sciences, Inc. | Stansky Michael P | Director | Award | $454.4K |
| Feb 11 | TLSI TriSalus Life Sciences, Inc. | Stansky Michael P | Director | Other | $0 |
| Nov 25 | TLSI TriSalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Officer | Grant | $666.0K |
| Nov 25 | TLSI TriSalus Life Sciences, Inc. | Stevens Jennifer | Chief Regulatory Officer | Grant | $555.0K |
| Nov 25 | TLSI TriSalus Life Sciences, Inc. | Cox Bryan F. | Chief of Research | Grant | $444.0K |
| Nov 25 | TLSI TriSalus Life Sciences, Inc. | Devlin Jodi | Chief of Clinical Operations | Grant | $555.0K |
| Nov 25 | TLSI TriSalus Life Sciences, Inc. | Patience David | Chief Financial Officer | Grant | $721.5K |
| Aug 29 | TLSI TriSalus Life Sciences, Inc. | Patience David | Chief Financial Officer | Award | $1.3M |
| Aug 15 | TLSI TriSalus Life Sciences, Inc. | Patience David | Chief Financial Officer | Grant | $1.1M |
| Apr 1 | TLSI TriSalus Life Sciences, Inc. | MATLIN DAVID J | Director | Conversion | $0 |
| Apr 20 | TLSI TriSalus Life Sciences, Inc. | Frankenius Equity AB | 10% Owner | Conversion | $0 |
| Nov 25 | TLSI TriSalus Life Sciences, Inc. | Szela Mary T | CEO and President, Director | Grant | $1.4M |
33 filings